Anavex Life Sciences Corp (AVXL)

[scratchy]

I beg to differ. Let’s say we have overwhelmingly good data. We already know we have a novel approach and MOA.

Now before screaming at the top of our lungs hey look at us we have these amazingly good results don’t you think it’s best to check and recheck and check again to make sure the data isn’t corrupted by some outside factor. You only get one chance to knock the scientific dinosaurs on their arse.

The company has already been giving us clues in their PR’s with statements saying disease modifying treatment, etc.

As much as I’d like to have everything laid out before me right now, I think this delay is far from worrisome.